These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1972733)

  • 1. Respective contributions of neuronal activity and presynaptic mechanisms in the control of the in vivo release of dopamine.
    Chéramy A; Barbeito L; Godeheu G; Desce JM; Pittaluga A; Galli T; Artaud F; Glowinski J
    J Neural Transm Suppl; 1990; 29():183-93. PubMed ID: 1972733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
    Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
    Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic regulation of dopaminergic transmission in the striatum.
    Glowinski J; Chéramy A; Romo R; Barbeito L
    Cell Mol Neurobiol; 1988 Mar; 8(1):7-17. PubMed ID: 2900072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L; Nieoullon A
    Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic dopaminergic modulation of cortical input to the striatum.
    Kornhuber J; Kornhuber ME
    Life Sci; 1986 Aug; 39(8):699-74. PubMed ID: 2874471
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones.
    Giorguieff-Chesselet MF; Besson MJ; Cheramy A; Glowinski J
    J Physiol (Paris); 1979; 75(6):611-3. PubMed ID: 547062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Involvement of glutamate released from cortico-striatal fibers in the presynaptic control of dopamine liberation in the caudal nucleus of the cat].
    Barbeito L; Godeheu G; Pittaluga A; Glowinski J
    Encephale; 1989; 15 Spec No():139-42. PubMed ID: 2568252
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo presynaptic control of dopamine release in the cat caudate nucleus--III. Further evidence for the implication of corticostriatal glutamatergic neurons.
    Romo R; Chéramy A; Godeheu G; Glowinski J
    Neuroscience; 1986 Dec; 19(4):1091-9. PubMed ID: 2881228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity.
    Meldrum A; Dunnett SB; Everitt BJ
    Neuroreport; 2001 Jan; 12(1):89-93. PubMed ID: 11201098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat.
    Galli T; Godeheu G; Artaud F; Desce JM; Pittaluga A; Barbeito L; Glowsinki J; Chéramy A
    Neuroscience; 1991; 42(1):19-28. PubMed ID: 1861773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal glutamatergic function: modifications following specific lesions.
    Roberts PJ; McBean GJ; Sharif NA; Thomas EM
    Brain Res; 1982 Mar; 235(1):83-91. PubMed ID: 6145487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum.
    Nieoullon A; Kerkerian L; Dusticier N
    Neurosci Lett; 1983 Dec; 43(2-3):191-6. PubMed ID: 6143287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum.
    Kerkerian L; Dusticier N; Nieoullon A
    J Neurochem; 1987 Apr; 48(4):1301-6. PubMed ID: 2880932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals.
    Johnson KM; Jeng YJ
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1416-21. PubMed ID: 1685693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative roles of neuronal activity and direct presynaptic mechanisms in controlling the release of dopamine from the cat caudate nucleus.
    Cheramy A; Romo R; Glowinski J
    Ann N Y Acad Sci; 1986; 473():80-91. PubMed ID: 2879497
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input.
    Keefe KA; Zigmond MJ; Abercrombie ED
    Neuroscience; 1992; 47(2):325-32. PubMed ID: 1353620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis.
    Chesselet MF
    Neuroscience; 1984 Jun; 12(2):347-75. PubMed ID: 6146946
    [No Abstract]   [Full Text] [Related]  

  • 20. The striatonigral substance P pathway and dopaminergic mechanisms.
    Glowinski J; Torrens Y; Beaujouan JC
    Ciba Found Symp; 1982; (91):281-95. PubMed ID: 6183075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.